Regulations.gov document
New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin; Florfenicol; Florfenicol…
Rule · FDA-2013-N-0002 · posted Apr 1, 2014
Key facts
| Document ID | FDA-2013-N-0002-0050 |
|---|---|
| Title | New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin; Florfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone; Pimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2013-N-0002 |
| Posted | Apr 1, 2014 |
| Federal Register citation | 79 FR 18156 |
| FR document number | 2014-07220 |
| CFR | 21 CFR Parts 510, 516, 520, 522, 526, and 558 |
| Comment period opens | Apr 1, 2014 |
| Effective date | Apr 1, 2014 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: